Related Experiment Video
Updated: Feb 15, 2026

Identification of Coding and Non-coding RNA Classes Expressed in Swine Whole Blood
Published on: November 28, 2018
Critical effects of long non-coding RNA on fibrosis diseases
Yue Zhang1,2,3, Gang Luo2, Yi Zhang4
1Department of Dermatology, 105th Hospital of PLA, Hefei, China.
Abstract:
The expression or dysfunction of long non-coding RNAs (lncRNAs) is closely related to various hereditary diseases, autoimmune diseases, metabolic diseases and tumors. LncRNAs were also recently recognized as functional regulators of fibrosis, which is a secondary process in many of these diseases and a primary pathology in fibrosis diseases. We review the latest findings on lncRNAs in fibrosis diseases of the liver, myocardium, kidney, lung and peritoneum. We also discuss the potential of disease-related lncRNAs as therapeutic targets for the clinical treatment of human fibrosis diseases.
Insights
Long non-coding RNAs (lncRNAs) are implicated in various diseases and regulate fibrosis. This review covers lncRNAs in liver, heart, kidney, lung, and peritoneal fibrosis, highlighting their therapeutic potential.
Area of Science:
- Molecular Biology
- Genetics
- Pathology
Background:
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in diverse diseases, including hereditary, autoimmune, metabolic, and oncological conditions.
- Fibrosis, a pathological process common in many diseases and a primary feature of fibrotic disorders, is now understood to be regulated by lncRNAs.
Purpose of the Study:
- To review the latest research on the role of lncRNAs in fibrotic diseases affecting major organs.
- To explore the potential of lncRNAs as therapeutic targets for human fibrotic diseases.
Main Methods:
- Literature review of recent findings on lncRNAs in fibrosis.
- Analysis of lncRNA involvement in liver, myocardial, kidney, lung, and peritoneal fibrosis.
Main Results:
- lncRNAs are significant regulators in the pathogenesis of fibrosis across multiple organs.
- Dysregulation of specific lncRNAs is associated with the development and progression of fibrotic diseases.
Conclusions:
- lncRNAs play a crucial role in the development of fibrosis in the liver, heart, kidney, lung, and peritoneum.
- Targeting disease-related lncRNAs offers promising therapeutic strategies for treating human fibrotic diseases.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
RNA Splicing
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Nursing Code of Ethics
Critical Region, Critical Values and Significance Level
In hypothesis testing, a sample statistic is converted to a test statistic using z, t, or chi-square distribution. A critical region is an area under the curve in probability distributions demarcated by the critical value. When the test statistic falls in this region, it suggests that the null hypothesis must be rejected. As this region contains all those values of the...

